Strides Pharma Science Ltd - 532531 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dhimant D Sangani22-08-2023
Strides Pharma Science Ltd - 532531 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 of SEBI Listing Regulations 2015Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Earnings Call transcript pertaining to un-audited Financial Results for the quarter ended June 30, 2023.Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication title ''Notice of 32nd Annual General Meeting, Remote E-Voting and Cut-Off Date''Strides Pharma Science Ltd - 532531 - Business Responsibility and Sustainability Reporting (BRSR)
Submission of Business Responsibility & Sustainability Report for FY23Strides Pharma Science Ltd - 532531 - Notice Of 32Nd Annual General Meeting And Annual Report For FY23
Notice of 32nd Annual General Meeting and Annual Report for FY23Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement - Unaudited Financial Results for the quarter ended June 30, 2023Strides Pharma Science Ltd - 532531 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation pursuant to Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio Recording of Earnings call pertaining to the un-audited Financial Results for the quarter ended June 30, 2023.